Where Is the “Optimal” Fontan Hemodynamics?
暂无分享,去创建一个
[1] Mark J Schuuring,et al. Impact of bosentan on exercise capacity in adults after the Fontan procedure: a randomized controlled trial , 2013, European journal of heart failure.
[2] P. Kamath,et al. Hepatocellular carcinoma after the Fontan procedure. , 2013, The New England journal of medicine.
[3] T. Levine,et al. Regional blood flow supply and demand in heart failure. , 1990, American heart journal.
[4] P. Poirier,et al. Impact of exercise training on muscle function and ergoreflex in Fontan patients: a pilot study. , 2006, International journal of cardiology.
[5] J. Tam,et al. Resolution of protein-losing enteropathy with low-molecular weight heparin in an adult patient with Fontan palliation. , 2007, The Annals of thoracic surgery.
[6] D. Ivy,et al. Evidence of pulmonary vascular disease after heart transplantation for Fontan circulation failure. , 2004, The Journal of thoracic and cardiovascular surgery.
[7] W. Book,et al. Clinical Phenotypes of Fontan Failure: Implications for Management. , 2016, Congenital heart disease.
[8] A. Hager,et al. Effect of sildenafil on haemodynamic response to exercise and exercise capacity in Fontan patients. , 2008, European heart journal.
[9] V. Fuster,et al. Contemporary medical management of systolic heart failure. , 2012, Circulation journal : official journal of the Japanese Circulation Society.
[10] R. Groszmann,et al. Phosphorylation of eNOS initiates excessive NO production in early phases of portal hypertension. , 2002, American journal of physiology. Heart and circulatory physiology.
[11] K. Schumacher,et al. Dopamine as a potential rescue therapy for refractory protein‐losing enteropathy in Fontan‐palliated patients , 2017, Pediatric transplantation.
[12] G. Kemp,et al. Resistance training improves cardiac output, exercise capacity and tolerance to positive airway pressure in Fontan physiology. , 2012, International journal of cardiology.
[13] S. Yazaki,et al. Haemodynamic characteristics before and after the onset of protein losing enteropathy in patients after the Fontan operation. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[14] D. Driscoll,et al. Prevalence and outcome of thrombotic and embolic complications in adults after Fontan operation , 2017, American heart journal.
[15] M. Ono,et al. Arrhythmias After Fontan Operation with Intra-atrial Lateral Tunnel Versus Extra-cardiac Conduit: A Systematic Review and Meta-analysis , 2017, Pediatric Cardiology.
[16] J. Rychik,et al. Lean mass deficits, vitamin D status and exercise capacity in children and young adults after Fontan palliation , 2014, Heart.
[17] T. Yagihara,et al. High prevalence of abnormal glucose metabolism in young adult patients with complex congenital heart disease. , 2009, American heart journal.
[18] Dionne A. Graham,et al. Effect of inhaled iloprost on the exercise function of Fontan patients: a demonstration of concept. , 2013, International journal of cardiology.
[19] N. S. Gaither,et al. Development of pulmonary arteriovenous malformations after modified Fontan operations. , 1989, The Journal of thoracic and cardiovascular surgery.
[20] H. Ohuchi,et al. Restrictive Ventilatory Impairment and Arterial Oxygenation Characterize Rest and Exercise Ventilation in Patients After Fontan Operation , 2004, Pediatric Cardiology.
[21] G. Stellin,et al. Effects of aerobic exercise training in children after the Fontan operation. , 2005, The American journal of cardiology.
[22] D. Driscoll,et al. The use of oral budesonide in adolescents and adults with protein-losing enteropathy after the Fontan operation. , 2011, The Annals of thoracic surgery.
[23] L. Bergamasco,et al. Endothelin inhibitors lower pulmonary vascular resistance and improve functional capacity in patients with Fontan circulation , 2017, The Journal of thoracic and cardiovascular surgery.
[24] H. Drexler. Reduced exercise tolerance in chronic heart failure and its relationship to neurohumoral factors. , 1991, European heart journal.
[25] M. Aoki,et al. Successful Fontan completion after cardiac resynchronization therapy. , 2012, Circulation.
[26] Y. D'udekem,et al. Long-term outcomes after first-onset arrhythmia in Fontan physiology. , 2016, The Journal of thoracic and cardiovascular surgery.
[27] Dionne A. Graham,et al. MELD-XI score and cardiac mortality or transplantation in patients after Fontan surgery , 2013, Heart.
[28] J. Myers,et al. Prospective, Longitudinal Study of Plastic Bronchitis Cast Pathology and Responsiveness to Tissue Plasminogen Activator , 2011, Pediatric Cardiology.
[29] C R Benedict,et al. Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD Investigators. , 1996, Circulation.
[30] S. Apostolopoulou,et al. Bosentan induces clinical, exercise and hemodynamic improvement in a pre-transplant patient with plastic bronchitis after Fontan operation. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[31] K. Sørensen,et al. Bosentan Improves Exercise Capacity in Adolescents and Adults After Fontan Operation: The TEMPO (Treatment With Endothelin Receptor Antagonist in Fontan Patients, a Randomized, Placebo-Controlled, Double-Blind Study Measuring Peak Oxygen Consumption) Study , 2014, Circulation.
[32] Emir Veledar,et al. Hemodynamic phenotype of the failing Fontan in an adult population. , 2013, The American journal of cardiology.
[33] D. Driscoll,et al. Sudden cardiac death and late arrhythmias after the Fontan operation , 2017, Congenital heart disease.
[34] M. Sugimoto,et al. Effectiveness of High-dose Spironolactone Therapy in a Patient with Recurrent Protein-losing Enteropathy after the Fontan Procedure. , 2016, Internal medicine.
[35] M. Mizuno,et al. Prevalence and predictors of haemostatic complications in 412 Fontan patients: their relation to anticoagulation and haemodynamics. , 2015, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[36] J. Rychik,et al. Percutaneous Lymphatic Embolization of Abnormal Pulmonary Lymphatic Flow as Treatment of Plastic Bronchitis in Patients With Congenital Heart Disease , 2016, Circulation.
[37] R. D. de Winter,et al. Percutaneous tricuspid valve implantation in a Fontan patient with congestive heart failure and protein-losing enteropathy. , 2011, Circulation. Cardiovascular interventions.
[38] M. Griselli,et al. Management of the failing Fontan. , 2015, Seminars in thoracic and cardiovascular surgery. Pediatric cardiac surgery annual.
[39] S. Solomon,et al. Survival with cardiac-resynchronization therapy in mild heart failure. , 2014, The New England journal of medicine.
[40] H. Uemura,et al. Influence of ventricular morphology on aerobic exercise capacity in patients after the Fontan operation. , 2001, Journal of the American College of Cardiology.
[41] A. Redington,et al. Atrioventricular valve repair in patients with functional single-ventricle physiology: impact of ventricular and valve function and morphology on survival and reintervention. , 2011, The Journal of thoracic and cardiovascular surgery.
[42] P. Kamath,et al. Liver Disease in Patients After the Fontan Operation. , 2016, The American journal of cardiology.
[43] E. Bacha,et al. Effects of lack of pulsatility on pulmonary endothelial function in the Fontan circulation. , 2013, The Journal of thoracic and cardiovascular surgery.
[44] M. Jacobs,et al. Management of the failing Fontan circulation , 2012, Heart.
[45] K. Sharkey,et al. Hyperdynamic circulation in portal‐hypertensive rats is dependent on central c‐fos gene expression , 2002, Hepatology.
[46] H. Ohuchi,et al. Long-term serial aerobic exercise capacity and hemodynamic properties in clinically and hemodynamically good, "excellent", Fontan survivors. , 2012, Circulation journal : official journal of the Japanese Circulation Society.
[47] H. Ohuchi. Adult patients with Fontan circulation: What we know and how to manage adults with Fontan circulation? , 2016, Journal of cardiology.
[48] John K. Triedman,et al. Long-Term Survival, Modes of Death, and Predictors of Mortality in Patients With Fontan Surgery , 2008, Circulation.
[49] J. Rychik,et al. Effect of Fontan-Associated Morbidities on Survival With Intact Fontan Circulation. , 2017, The American journal of cardiology.
[50] Andrew H Van Bergen,et al. Long-term treatment of plastic bronchitis with aerosolized tissue plasminogen activator in a Fontan patient , 2005, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[51] F. Wong. Cirrhotic cardiomyopathy , 2009, Hepatology international.
[52] P. Schumacker,et al. Hypoxia-induced changes in pulmonary and systemic vascular resistance: Where is the O2 sensor? , 2010, Respiratory Physiology & Neurobiology.
[53] H. Matsuda,et al. Heart transplantation for adults with congenital heart disease: current status and future prospects , 2017, General Thoracic and Cardiovascular Surgery.
[54] Orhan Uzun,et al. Resolution of protein-losing enteropathy and normalization of mesenteric Doppler flow with sildenafil after Fontan. , 2006, The Annals of thoracic surgery.
[55] M. Mizuno,et al. Comparison of prognostic variables in children and adults with Fontan circulation. , 2014, International journal of cardiology.
[56] J. Rychik,et al. Deficits in bone density and structure in children and young adults following Fontan palliation. , 2015, Bone.
[57] J. Fragata,et al. Thoracic Duct Decompression for Protein-Losing Enteropathy in Failing Fontan Circulation. , 2016, The Annals of thoracic surgery.
[58] Makoto Mori,et al. Catheter-measured Hemodynamics of Adult Fontan Circulation: Associations with Adverse Event and End-organ Dysfunctions. , 2016, Congenital heart disease.
[59] R. Groszmann,et al. The hyperdynamic circulation of chronic liver diseases: From the patient to the molecule , 2006, Hepatology.
[60] F. Fontan,et al. Surgical repair of tricuspid atresia , 1971, Thorax.
[61] I. Shiraishi,et al. Renal resistive index reflects Fontan pathophysiology and predicts mortality , 2017, Heart.
[62] Rebecca G. Wells,et al. The Precarious State of the Liver After a Fontan Operation: Summary of a Multidisciplinary Symposium , 2012, Pediatric Cardiology.
[63] M. Heinemann,et al. Incidence and impact of systemic venous collateral development after Glenn and Fontan procedures. , 2001, The Thoracic and cardiovascular surgeon.
[64] L. Hudsmith,et al. Prevalence of atrial tachyarrhythmia in adults after Fontan operation , 2015, Heart.
[65] C. Brizard,et al. The Fontan Procedure: Contemporary Techniques Have Improved Long-Term Outcomes , 2007, Circulation.
[66] D. Schranz,et al. Aortopulmonary Collateral Flow Is Related to Pulmonary Artery Size and Affects Ventricular Dimensions in Patients after the Fontan Procedure , 2013, PloS one.
[67] I. Shiraishi,et al. Hemodynamic determinants of mortality after Fontan operation , 2017, American heart journal.
[68] K. Dimopoulos,et al. Survival Prospects and Circumstances of Death in Contemporary Adult Congenital Heart Disease Patients Under Follow-Up at a Large Tertiary Centre , 2015, Circulation.
[69] D. Driscoll,et al. Clinical outcomes and improved survival in patients with protein-losing enteropathy after the Fontan operation. , 2014, Journal of the American College of Cardiology.
[70] N. Méndez-Sánchez,et al. Hepatorenal syndrome: Current concepts related to diagnosis and management. , 2016, Annals of hepatology.
[71] I. Konstantinov,et al. Meta-Analysis of the Effectiveness of Heart Transplantation in Patients With a Failing Fontan. , 2017, The American journal of cardiology.
[72] Y. D'udekem,et al. Common atrioventricular valve failure during single ventricle palliation† , 2017, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[73] H. Heidbuchel,et al. Sildenafil Improves Exercise Hemodynamics in Fontan Patients , 2014, Circulation. Cardiovascular imaging.
[74] J. Rychik,et al. Impact of Oral Sildenafil on Exercise Performance in Children and Young Adults After the Fontan Operation: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial , 2011, Circulation.
[75] Makoto Mori,et al. Beyond a Broken Heart: Circulatory Dysfunction in the Failing Fontan , 2014, Pediatric Cardiology.
[76] H. Ichikawa,et al. Impact of the evolution of the Fontan operation on early and late mortality: a single-center experience of 405 patients over 3 decades. , 2011, The Annals of thoracic surgery.